AAAAAA

   
Results: 1-5 |
Results: 5

Authors: Bonfigli, AR Pieri, C Manfrini, S Testa, I Sirolla, C Ricciotti, R Marra, M Compagnucci, P Testa, R
Citation: Ar. Bonfigli et al., Vitamin E intake reduces plasminogen activator inhibitor type 1 in T2DM patients, DIABET NUTR, 14(2), 2001, pp. 71-77

Authors: Boemi, M Leviev, I Sirolla, C Pieri, C Marra, M James, RW
Citation: M. Boemi et al., Serum paraoxonase is reduced in type 1 diabetic patients compared to non-diabetic, first degree relatives; influence on the ability of HDL to protectLDL from oxidation, ATHEROSCLER, 155(1), 2001, pp. 229-235

Authors: Testa, R Bonfigli, AR Sirolla, C De Grazia, G Compagnucci, P Manfrini, S Fumelli, D Testa, I
Citation: R. Testa et al., Fibronectin and lipoprotein(a) are inversely related to plasminogen activator inhibitor type-1 levels in Type 2 diabetic patients without complications, DIABET NUTR, 13(5), 2000, pp. 269-275

Authors: Testa, R Bonfigli, AR Sirolla, C Marra, M Antonicelli, R Manfrini, S Compagnucci, P Testa, I
Citation: R. Testa et al., A strong inverse relationship between PAI-1 and Lp(a) in hypertensive Type2 diabetic patients, DIABET NUTR, 12(6), 1999, pp. 400-406

Authors: Boemi, M Sirolla, C Fumelli, P James, RW
Citation: M. Boemi et al., Renal disease as a determinant of increased lipoprotein(a) concentrations in diabetic patients, DIABET CARE, 22(12), 1999, pp. 2033-2036
Risultati: 1-5 |